Revolutionary iPSC line poised to accelerate development of groundbreaking treatments SEATTLE, January 07, 2025–Pluristyx, a leading provider of Good Manufacturing Practices (GMP), cutting-edge, induced pluripotent stem cell (iPSC) technologies, today announced the immediate availability of the PSXi013 iPSC line made under GMP. This off-the-shelf, readily available cell line will revolutionize the cell and gene therapy […]
Proceeds from the financing will be used to broaden and improve the company’s offerings and for operational expansion across facilities, quality, and commercial. CAMARILLO, CA — PBS Biotech (“PBS”), a provider of innovative single-use bioreactor systems and bioprocess development services, has secured $17 million in follow-on growth capital from Avego Management, LLC (“Avego”) and BroadOak […]
Acquisition will advance company’s cell culture portfolio with internationally recognized pioneer in organoid development Burlington, Massachusetts, United States of America Reinforces company’s commitment to differentiated solutions that enable faster and more effective drug development HUB’s organoid offering complements company’s cell culture portfolio of media, reagents, and benchtop instrumentation Organoids provide drug response data earlier in […]
SAN DIEGO — PhenoVista Biosciences, a contract research organization (CRO) and leading provider of both custom and off-the-shelf, imaging-based assay services based in San Diego, California, announces their new commercial partnership with NETRI, a world leader manufacturer of microfluidic devices for high-throughput screening (HTS) based in Lyon, France. This partnership will combine PhenoVista’s extensive experience […]
BILLERICA, Mass.–Bruker Corporation (Nasdaq: BRKR) today commented on the ruling of the U.S. District Court for the District of Delaware in the case involving GeoMx® Digital Spatial Profiler products sold by its NanoString business. Yesterday, the Court issued its ruling on the post-trial motions that followed the November 2023 jury verdict in the patent infringement […]
ROCKVILLE, MD – MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that Art Mandell has retired from his position as a member of the Board of Directors of MaxCyte effective December 31, 2024. Mr. Mandell […]
PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. To minimize the […]
DKSH will utilize its market expansion expertise to introduce Countstar’s innovative cell analysis systems into Malaysia, driving growth in the life sciences and biopharma sectors with cutting-edge technology and comprehensive distribution services. Petaling Jaya, Malaysia – DKSH Business Unit Technology has formed a partnership with Countstar, a leading cell analysis solutions provider, in Malaysia. The […]
Palo Alto, California – Just as the transistor and microscope unlocked new waves of discovery, today, GenBio AI opens the doors to a new era of scientific exploration with Phase 1 of the world’s first AI-Driven Digital Organism (AIDO). In this first phase, scientists will have access to not one, but six groundbreaking models that […]
Proprietary Next-Generation Non-Viral, Non-Electroporative Transfection Platform Gaining Traction in Cell Therapy Market ALAMEDA, Calif.–CellFE®, a disruptive life sciences company marketing non-viral, non-electroporative cell therapy manufacturing tools, today announced several strategic system placements with major pharmaceutical and biotech companies, as well as leading translational medicine centers in the cell therapy market. These placements follow the successful […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
